Cathie Wood acquired 11 Million Fate Therapeutics shares worth $294 Million. That's 1.76% of their equity portfolio (18th largest holding). The investor owns 11.9% of the outstanding Fate Therapeutics stock. The first Fate Therapeutics trade was made in Q4 2019. Since then Cathie Wood bought shares eight more times and sold shares on one occasions. The investor's estimated purchase price is $805 Million, resulting in a loss of 63%.